nodes	percent_of_prediction	percent_of_DWPC	metapath
Propiomazine—DRD4—bipolar disorder	0.22	0.276	CbGaD
Propiomazine—DRD1—bipolar disorder	0.186	0.233	CbGaD
Propiomazine—HTR2C—bipolar disorder	0.159	0.2	CbGaD
Propiomazine—DRD2—bipolar disorder	0.131	0.164	CbGaD
Propiomazine—HTR2A—bipolar disorder	0.101	0.127	CbGaD
Propiomazine—DRD1—telencephalic ventricle—bipolar disorder	0.00546	0.128	CbGeAlD
Propiomazine—HTR2A—locus ceruleus—bipolar disorder	0.00448	0.105	CbGeAlD
Propiomazine—HTR2C—telencephalic ventricle—bipolar disorder	0.00424	0.0996	CbGeAlD
Propiomazine—DRD2—telencephalic ventricle—bipolar disorder	0.00322	0.0757	CbGeAlD
Propiomazine—HTR2A—autonomic nervous system—bipolar disorder	0.00238	0.056	CbGeAlD
Propiomazine—HTR2A—telencephalic ventricle—bipolar disorder	0.00213	0.05	CbGeAlD
Propiomazine—HTR2A—urine—bipolar disorder	0.00194	0.0456	CbGeAlD
Propiomazine—DRD4—brain—bipolar disorder	0.00117	0.0276	CbGeAlD
Propiomazine—CHRM4—nervous system—bipolar disorder	0.00116	0.0273	CbGeAlD
Propiomazine—HTR2A—blood plasma—bipolar disorder	0.00101	0.0238	CbGeAlD
Propiomazine—CHRM5—nervous system—bipolar disorder	0.000908	0.0213	CbGeAlD
Propiomazine—CHRM4—brain—bipolar disorder	0.000888	0.0209	CbGeAlD
Propiomazine—ADRA1B—nervous system—bipolar disorder	0.00083	0.0195	CbGeAlD
Propiomazine—ADRA1D—nervous system—bipolar disorder	0.000812	0.0191	CbGeAlD
Propiomazine—DRD1—nervous system—bipolar disorder	0.000773	0.0182	CbGeAlD
Propiomazine—CHRM5—brain—bipolar disorder	0.000694	0.0163	CbGeAlD
Propiomazine—ADRA1B—brain—bipolar disorder	0.000634	0.0149	CbGeAlD
Propiomazine—CHRM2—nervous system—bipolar disorder	0.000623	0.0146	CbGeAlD
Propiomazine—ADRA1D—brain—bipolar disorder	0.00062	0.0146	CbGeAlD
Propiomazine—CHRM3—thyroid gland—bipolar disorder	0.000604	0.0142	CbGeAlD
Propiomazine—HTR2C—nervous system—bipolar disorder	0.000601	0.0141	CbGeAlD
Propiomazine—DRD1—brain—bipolar disorder	0.000591	0.0139	CbGeAlD
Propiomazine—CHRM1—nervous system—bipolar disorder	0.000567	0.0133	CbGeAlD
Propiomazine—CHRM3—nervous system—bipolar disorder	0.000508	0.0119	CbGeAlD
Propiomazine—CHRM2—brain—bipolar disorder	0.000476	0.0112	CbGeAlD
Propiomazine—ADRA1A—nervous system—bipolar disorder	0.000466	0.011	CbGeAlD
Propiomazine—HTR2C—brain—bipolar disorder	0.000459	0.0108	CbGeAlD
Propiomazine—DRD2—nervous system—bipolar disorder	0.000457	0.0107	CbGeAlD
Propiomazine—ADRA1A—cerebellum—bipolar disorder	0.000439	0.0103	CbGeAlD
Propiomazine—CHRM1—brain—bipolar disorder	0.000434	0.0102	CbGeAlD
Propiomazine—DRD2—cerebellum—bipolar disorder	0.00043	0.0101	CbGeAlD
Propiomazine—CHRM3—brain—bipolar disorder	0.000388	0.00912	CbGeAlD
Propiomazine—HRH1—nervous system—bipolar disorder	0.000361	0.00848	CbGeAlD
Propiomazine—ADRA1A—brain—bipolar disorder	0.000356	0.00837	CbGeAlD
Propiomazine—DRD2—brain—bipolar disorder	0.000349	0.00821	CbGeAlD
Propiomazine—HTR2A—nervous system—bipolar disorder	0.000301	0.00708	CbGeAlD
Propiomazine—HTR2A—cerebellum—bipolar disorder	0.000284	0.00666	CbGeAlD
Propiomazine—HRH1—brain—bipolar disorder	0.000276	0.00648	CbGeAlD
Propiomazine—Diltiazem—CACNA1C—bipolar disorder	0.000238	0.0314	CrCbGaD
Propiomazine—HTR2A—brain—bipolar disorder	0.00023	0.00541	CbGeAlD
Propiomazine—Acetophenazine—DRD1—bipolar disorder	0.000216	0.0285	CrCbGaD
Propiomazine—Methotrimeprazine—DRD5—bipolar disorder	0.000194	0.0255	CrCbGaD
Propiomazine—Propericiazine—DRD1—bipolar disorder	0.000191	0.0252	CrCbGaD
Propiomazine—Cyamemazine—HTR2C—bipolar disorder	0.000163	0.0215	CrCbGaD
Propiomazine—Acetophenazine—DRD2—bipolar disorder	0.000152	0.0201	CrCbGaD
Propiomazine—Chlorpromazine—DRD5—bipolar disorder	0.000148	0.0195	CrCbGaD
Propiomazine—Triflupromazine—DRD1—bipolar disorder	0.000133	0.0175	CrCbGaD
Propiomazine—Acepromazine—DRD1—bipolar disorder	0.000123	0.0162	CrCbGaD
Propiomazine—Thioproperazine—DRD1—bipolar disorder	0.00012	0.0158	CrCbGaD
Propiomazine—Mesoridazine—DRD3—bipolar disorder	0.000119	0.0156	CrCbGaD
Propiomazine—Thiothixene—DRD1—bipolar disorder	0.000118	0.0155	CrCbGaD
Propiomazine—Pipotiazine—DRD1—bipolar disorder	0.000118	0.0155	CrCbGaD
Propiomazine—Prochlorperazine—DRD3—bipolar disorder	0.000115	0.0151	CrCbGaD
Propiomazine—Cyamemazine—HTR2A—bipolar disorder	0.000104	0.0137	CrCbGaD
Propiomazine—Fluphenazine—DRD3—bipolar disorder	0.000104	0.0137	CrCbGaD
Propiomazine—Fluphenazine—DRD1—bipolar disorder	0.000102	0.0134	CrCbGaD
Propiomazine—Acepromazine—HTR1A—bipolar disorder	0.000102	0.0134	CrCbGaD
Propiomazine—Thiothixene—HTR2C—bipolar disorder	0.000101	0.0133	CrCbGaD
Propiomazine—Mesoridazine—HTR2C—bipolar disorder	9.96e-05	0.0131	CrCbGaD
Propiomazine—Thioproperazine—HTR1A—bipolar disorder	9.95e-05	0.0131	CrCbGaD
Propiomazine—Methotrimeprazine—DRD4—bipolar disorder	9.9e-05	0.0131	CrCbGaD
Propiomazine—Thiothixene—HTR1A—bipolar disorder	9.79e-05	0.0129	CrCbGaD
Propiomazine—Pipotiazine—HTR1A—bipolar disorder	9.79e-05	0.0129	CrCbGaD
Propiomazine—Mesoridazine—HTR1A—bipolar disorder	9.66e-05	0.0127	CrCbGaD
Propiomazine—Prochlorperazine—HTR2C—bipolar disorder	9.64e-05	0.0127	CrCbGaD
Propiomazine—Chlorprothixene—DRD3—bipolar disorder	9.45e-05	0.0125	CrCbGaD
Propiomazine—Triflupromazine—DRD2—bipolar disorder	9.34e-05	0.0123	CrCbGaD
Propiomazine—Chlorprothixene—DRD1—bipolar disorder	9.28e-05	0.0122	CrCbGaD
Propiomazine—Thioridazine—DRD1—bipolar disorder	8.78e-05	0.0116	CrCbGaD
Propiomazine—Fluphenazine—HTR2C—bipolar disorder	8.72e-05	0.0115	CrCbGaD
Propiomazine—Acepromazine—DRD2—bipolar disorder	8.65e-05	0.0114	CrCbGaD
Propiomazine—Promazine—DRD4—bipolar disorder	8.58e-05	0.0113	CrCbGaD
Propiomazine—Methotrimeprazine—DRD3—bipolar disorder	8.54e-05	0.0113	CrCbGaD
Propiomazine—Fluphenazine—HTR1A—bipolar disorder	8.46e-05	0.0112	CrCbGaD
Propiomazine—Thioproperazine—DRD2—bipolar disorder	8.45e-05	0.0111	CrCbGaD
Propiomazine—Methotrimeprazine—DRD1—bipolar disorder	8.38e-05	0.011	CrCbGaD
Propiomazine—Pipotiazine—DRD2—bipolar disorder	8.31e-05	0.011	CrCbGaD
Propiomazine—Thiothixene—DRD2—bipolar disorder	8.31e-05	0.011	CrCbGaD
Propiomazine—Mesoridazine—DRD2—bipolar disorder	8.2e-05	0.0108	CrCbGaD
Propiomazine—Trimipramine—SLC6A3—bipolar disorder	8.13e-05	0.0107	CrCbGaD
Propiomazine—Perphenazine—DRD1—bipolar disorder	8.06e-05	0.0106	CrCbGaD
Propiomazine—Clomipramine—HTR2C—bipolar disorder	7.97e-05	0.0105	CrCbGaD
Propiomazine—Prochlorperazine—DRD2—bipolar disorder	7.94e-05	0.0105	CrCbGaD
Propiomazine—Chlorprothixene—HTR2C—bipolar disorder	7.94e-05	0.0105	CrCbGaD
Propiomazine—Chlorpromazine—DRD4—bipolar disorder	7.55e-05	0.00996	CrCbGaD
Propiomazine—Thioridazine—HTR2C—bipolar disorder	7.51e-05	0.0099	CrCbGaD
Propiomazine—Trimipramine—HTR2C—bipolar disorder	7.34e-05	0.00967	CrCbGaD
Propiomazine—Thioridazine—HTR1A—bipolar disorder	7.29e-05	0.00961	CrCbGaD
Propiomazine—Promazine—DRD1—bipolar disorder	7.26e-05	0.00957	CrCbGaD
Propiomazine—Fluphenazine—DRD2—bipolar disorder	7.18e-05	0.00947	CrCbGaD
Propiomazine—Methotrimeprazine—HTR2C—bipolar disorder	7.17e-05	0.00945	CrCbGaD
Propiomazine—Trimipramine—HTR1A—bipolar disorder	7.12e-05	0.00939	CrCbGaD
Propiomazine—Trifluoperazine—HTR2C—bipolar disorder	6.97e-05	0.00919	CrCbGaD
Propiomazine—Perphenazine—HTR2C—bipolar disorder	6.89e-05	0.00909	CrCbGaD
Propiomazine—Trifluoperazine—HTR1A—bipolar disorder	6.77e-05	0.00892	CrCbGaD
Propiomazine—Perphenazine—HTR1A—bipolar disorder	6.69e-05	0.00882	CrCbGaD
Propiomazine—Acepromazine—HTR2A—bipolar disorder	6.68e-05	0.00881	CrCbGaD
Propiomazine—Clomipramine—SLC6A4—bipolar disorder	6.61e-05	0.00871	CrCbGaD
Propiomazine—Chlorprothixene—DRD2—bipolar disorder	6.54e-05	0.00862	CrCbGaD
Propiomazine—Thioproperazine—HTR2A—bipolar disorder	6.53e-05	0.00861	CrCbGaD
Propiomazine—Chlorpromazine—DRD3—bipolar disorder	6.51e-05	0.00858	CrCbGaD
Propiomazine—Thiothixene—HTR2A—bipolar disorder	6.42e-05	0.00847	CrCbGaD
Propiomazine—Pipotiazine—HTR2A—bipolar disorder	6.42e-05	0.00847	CrCbGaD
Propiomazine—Chlorpromazine—DRD1—bipolar disorder	6.39e-05	0.00843	CrCbGaD
Propiomazine—Mesoridazine—HTR2A—bipolar disorder	6.34e-05	0.00836	CrCbGaD
Propiomazine—Promazine—HTR2C—bipolar disorder	6.21e-05	0.00819	CrCbGaD
Propiomazine—Thioridazine—DRD2—bipolar disorder	6.19e-05	0.00816	CrCbGaD
Propiomazine—Trimipramine—SLC6A4—bipolar disorder	6.08e-05	0.00801	CrCbGaD
Propiomazine—Trimipramine—DRD2—bipolar disorder	6.05e-05	0.00797	CrCbGaD
Propiomazine—Methotrimeprazine—DRD2—bipolar disorder	5.91e-05	0.00779	CrCbGaD
Propiomazine—Promethazine—DRD2—bipolar disorder	5.82e-05	0.00767	CrCbGaD
Propiomazine—Trifluoperazine—DRD2—bipolar disorder	5.74e-05	0.00757	CrCbGaD
Propiomazine—Perphenazine—DRD2—bipolar disorder	5.68e-05	0.00749	CrCbGaD
Propiomazine—Fluphenazine—HTR2A—bipolar disorder	5.55e-05	0.00732	CrCbGaD
Propiomazine—Chlorpromazine—HTR2C—bipolar disorder	5.47e-05	0.00721	CrCbGaD
Propiomazine—Chlorpromazine—HTR1A—bipolar disorder	5.31e-05	0.007	CrCbGaD
Propiomazine—Promazine—DRD2—bipolar disorder	5.12e-05	0.00675	CrCbGaD
Propiomazine—Clomipramine—HTR2A—bipolar disorder	5.08e-05	0.00669	CrCbGaD
Propiomazine—Chlorprothixene—HTR2A—bipolar disorder	5.06e-05	0.00666	CrCbGaD
Propiomazine—Thioridazine—HTR2A—bipolar disorder	4.78e-05	0.0063	CrCbGaD
Propiomazine—Trimipramine—HTR2A—bipolar disorder	4.67e-05	0.00616	CrCbGaD
Propiomazine—Methotrimeprazine—HTR2A—bipolar disorder	4.57e-05	0.00602	CrCbGaD
Propiomazine—Chlorpromazine—DRD2—bipolar disorder	4.51e-05	0.00594	CrCbGaD
Propiomazine—Promethazine—HTR2A—bipolar disorder	4.5e-05	0.00593	CrCbGaD
Propiomazine—Trifluoperazine—HTR2A—bipolar disorder	4.44e-05	0.00585	CrCbGaD
Propiomazine—Perphenazine—HTR2A—bipolar disorder	4.39e-05	0.00579	CrCbGaD
Propiomazine—Promazine—HTR2A—bipolar disorder	3.96e-05	0.00522	CrCbGaD
Propiomazine—Chlorpromazine—HTR2A—bipolar disorder	3.48e-05	0.00459	CrCbGaD
Propiomazine—CHRM2—Signaling Pathways—PDE4B—bipolar disorder	1.18e-05	7.78e-05	CbGpPWpGaD
Propiomazine—CHRM2—Signaling Pathways—TSHB—bipolar disorder	1.18e-05	7.78e-05	CbGpPWpGaD
Propiomazine—CHRM2—Signaling Pathways—TACR1—bipolar disorder	1.18e-05	7.78e-05	CbGpPWpGaD
Propiomazine—ADRA1A—Signaling Pathways—PDE4B—bipolar disorder	1.18e-05	7.76e-05	CbGpPWpGaD
Propiomazine—ADRA1A—Signaling Pathways—TSHB—bipolar disorder	1.18e-05	7.76e-05	CbGpPWpGaD
Propiomazine—ADRA1A—Signaling Pathways—TACR1—bipolar disorder	1.18e-05	7.76e-05	CbGpPWpGaD
Propiomazine—CHRM4—Signaling by GPCR—POMC—bipolar disorder	1.18e-05	7.75e-05	CbGpPWpGaD
Propiomazine—ADRA1D—GPCR downstream signaling—POMC—bipolar disorder	1.17e-05	7.68e-05	CbGpPWpGaD
Propiomazine—HTR2C—Signaling by GPCR—HTR2A—bipolar disorder	1.15e-05	7.58e-05	CbGpPWpGaD
Propiomazine—HTR2C—Signaling Pathways—HTR1A—bipolar disorder	1.15e-05	7.55e-05	CbGpPWpGaD
Propiomazine—DRD1—Signaling Pathways—ADCY2—bipolar disorder	1.15e-05	7.55e-05	CbGpPWpGaD
Propiomazine—DRD1—Signaling Pathways—TCF7L2—bipolar disorder	1.15e-05	7.52e-05	CbGpPWpGaD
Propiomazine—DRD4—Signaling Pathways—NTRK1—bipolar disorder	1.14e-05	7.51e-05	CbGpPWpGaD
Propiomazine—CHRM3—Metabolism—SNAP25—bipolar disorder	1.14e-05	7.51e-05	CbGpPWpGaD
Propiomazine—DRD1—Signaling Pathways—DRD2—bipolar disorder	1.14e-05	7.47e-05	CbGpPWpGaD
Propiomazine—ADRA1D—Signaling Pathways—ADCY2—bipolar disorder	1.13e-05	7.45e-05	CbGpPWpGaD
Propiomazine—HTR2C—Signaling Pathways—TAC1—bipolar disorder	1.13e-05	7.44e-05	CbGpPWpGaD
Propiomazine—CHRM5—Signaling by GPCR—POMC—bipolar disorder	1.13e-05	7.42e-05	CbGpPWpGaD
Propiomazine—ADRA1D—Signaling Pathways—TCF7L2—bipolar disorder	1.13e-05	7.42e-05	CbGpPWpGaD
Propiomazine—CHRM4—Signaling Pathways—NTRK1—bipolar disorder	1.13e-05	7.41e-05	CbGpPWpGaD
Propiomazine—ADRA1D—Signaling Pathways—DRD2—bipolar disorder	1.12e-05	7.37e-05	CbGpPWpGaD
Propiomazine—DRD2—GPCR downstream signaling—HTR2A—bipolar disorder	1.12e-05	7.36e-05	CbGpPWpGaD
Propiomazine—DRD4—Signaling Pathways—S100B—bipolar disorder	1.11e-05	7.3e-05	CbGpPWpGaD
Propiomazine—HTR2C—Signaling Pathways—DRD1—bipolar disorder	1.11e-05	7.3e-05	CbGpPWpGaD
Propiomazine—ADRA1B—Signaling by GPCR—HTR2A—bipolar disorder	1.1e-05	7.25e-05	CbGpPWpGaD
Propiomazine—ADRA1B—Signaling Pathways—HTR1A—bipolar disorder	1.1e-05	7.23e-05	CbGpPWpGaD
Propiomazine—HRH1—GPCR downstream signaling—HTR2A—bipolar disorder	1.1e-05	7.23e-05	CbGpPWpGaD
Propiomazine—CHRM1—GPCR downstream signaling—HTR2A—bipolar disorder	1.1e-05	7.21e-05	CbGpPWpGaD
Propiomazine—CHRM4—Signaling Pathways—S100B—bipolar disorder	1.1e-05	7.2e-05	CbGpPWpGaD
Propiomazine—CHRM3—GPCR downstream signaling—HTR2A—bipolar disorder	1.09e-05	7.18e-05	CbGpPWpGaD
Propiomazine—ADRA1B—Signaling Pathways—TAC1—bipolar disorder	1.08e-05	7.12e-05	CbGpPWpGaD
Propiomazine—CHRM2—GPCR downstream signaling—HTR2A—bipolar disorder	1.08e-05	7.11e-05	CbGpPWpGaD
Propiomazine—CHRM5—Signaling Pathways—NTRK1—bipolar disorder	1.08e-05	7.1e-05	CbGpPWpGaD
Propiomazine—HTR2C—Signaling Pathways—NTRK2—bipolar disorder	1.08e-05	7.1e-05	CbGpPWpGaD
Propiomazine—ADRA1A—GPCR downstream signaling—HTR2A—bipolar disorder	1.08e-05	7.09e-05	CbGpPWpGaD
Propiomazine—DRD1—Signaling by GPCR—POMC—bipolar disorder	1.08e-05	7.07e-05	CbGpPWpGaD
Propiomazine—HTR2C—Signaling Pathways—DRD3—bipolar disorder	1.08e-05	7.07e-05	CbGpPWpGaD
Propiomazine—HTR2C—Signaling Pathways—GSK3A—bipolar disorder	1.07e-05	7.04e-05	CbGpPWpGaD
Propiomazine—ADRA1B—Signaling Pathways—HTR2C—bipolar disorder	1.06e-05	6.98e-05	CbGpPWpGaD
Propiomazine—ADRA1B—Signaling Pathways—DRD1—bipolar disorder	1.06e-05	6.98e-05	CbGpPWpGaD
Propiomazine—ADRA1D—Signaling by GPCR—POMC—bipolar disorder	1.06e-05	6.98e-05	CbGpPWpGaD
Propiomazine—CHRM5—Signaling Pathways—S100B—bipolar disorder	1.05e-05	6.9e-05	CbGpPWpGaD
Propiomazine—HTR2C—Signaling Pathways—DRD4—bipolar disorder	1.04e-05	6.86e-05	CbGpPWpGaD
Propiomazine—ADRA1B—Signaling Pathways—NTRK2—bipolar disorder	1.03e-05	6.79e-05	CbGpPWpGaD
Propiomazine—ADRA1B—Signaling Pathways—DRD3—bipolar disorder	1.03e-05	6.76e-05	CbGpPWpGaD
Propiomazine—DRD1—Signaling Pathways—NTRK1—bipolar disorder	1.03e-05	6.76e-05	CbGpPWpGaD
Propiomazine—ADRA1B—Signaling Pathways—GSK3A—bipolar disorder	1.03e-05	6.73e-05	CbGpPWpGaD
Propiomazine—DRD2—Signaling by GPCR—HTR2A—bipolar disorder	1.02e-05	6.69e-05	CbGpPWpGaD
Propiomazine—ADRA1D—Signaling Pathways—NTRK1—bipolar disorder	1.02e-05	6.67e-05	CbGpPWpGaD
Propiomazine—DRD2—Signaling Pathways—HTR1A—bipolar disorder	1.02e-05	6.67e-05	CbGpPWpGaD
Propiomazine—HTR2C—GPCR downstream signaling—POMC—bipolar disorder	1.01e-05	6.66e-05	CbGpPWpGaD
Propiomazine—CHRM3—Metabolism—ADCY2—bipolar disorder	1.01e-05	6.65e-05	CbGpPWpGaD
Propiomazine—DRD1—Signaling Pathways—S100B—bipolar disorder	1e-05	6.57e-05	CbGpPWpGaD
Propiomazine—ADRA1B—Signaling Pathways—DRD4—bipolar disorder	1e-05	6.57e-05	CbGpPWpGaD
Propiomazine—DRD2—Signaling Pathways—TAC1—bipolar disorder	1e-05	6.57e-05	CbGpPWpGaD
Propiomazine—HRH1—Signaling by GPCR—HTR2A—bipolar disorder	1e-05	6.57e-05	CbGpPWpGaD
Propiomazine—HTR2A—Signaling Pathways—HTR1A—bipolar disorder	9.99e-06	6.56e-05	CbGpPWpGaD
Propiomazine—HRH1—Signaling Pathways—HTR1A—bipolar disorder	9.97e-06	6.55e-05	CbGpPWpGaD
Propiomazine—CHRM1—Signaling by GPCR—HTR2A—bipolar disorder	9.96e-06	6.54e-05	CbGpPWpGaD
Propiomazine—CHRM1—Signaling Pathways—HTR1A—bipolar disorder	9.94e-06	6.52e-05	CbGpPWpGaD
Propiomazine—CHRM3—Signaling by GPCR—HTR2A—bipolar disorder	9.93e-06	6.52e-05	CbGpPWpGaD
Propiomazine—CHRM3—Signaling Pathways—HTR1A—bipolar disorder	9.9e-06	6.5e-05	CbGpPWpGaD
Propiomazine—ADRA1D—Signaling Pathways—S100B—bipolar disorder	9.88e-06	6.49e-05	CbGpPWpGaD
Propiomazine—HTR2A—Signaling Pathways—TAC1—bipolar disorder	9.84e-06	6.46e-05	CbGpPWpGaD
Propiomazine—CHRM2—Signaling by GPCR—HTR2A—bipolar disorder	9.84e-06	6.46e-05	CbGpPWpGaD
Propiomazine—HTR2C—Signaling Pathways—ADCY2—bipolar disorder	9.83e-06	6.46e-05	CbGpPWpGaD
Propiomazine—HRH1—Signaling Pathways—TAC1—bipolar disorder	9.82e-06	6.45e-05	CbGpPWpGaD
Propiomazine—DRD4—Signaling Pathways—NRG1—bipolar disorder	9.81e-06	6.45e-05	CbGpPWpGaD
Propiomazine—ADRA1A—Signaling by GPCR—HTR2A—bipolar disorder	9.81e-06	6.44e-05	CbGpPWpGaD
Propiomazine—CHRM2—Signaling Pathways—HTR1A—bipolar disorder	9.81e-06	6.44e-05	CbGpPWpGaD
Propiomazine—DRD2—Signaling Pathways—DRD1—bipolar disorder	9.81e-06	6.44e-05	CbGpPWpGaD
Propiomazine—DRD2—Signaling Pathways—HTR2C—bipolar disorder	9.81e-06	6.44e-05	CbGpPWpGaD
Propiomazine—HTR2C—Signaling Pathways—TCF7L2—bipolar disorder	9.8e-06	6.43e-05	CbGpPWpGaD
Propiomazine—CHRM1—Signaling Pathways—TAC1—bipolar disorder	9.79e-06	6.43e-05	CbGpPWpGaD
Propiomazine—ADRA1A—Signaling Pathways—HTR1A—bipolar disorder	9.78e-06	6.42e-05	CbGpPWpGaD
Propiomazine—CHRM3—Signaling Pathways—TAC1—bipolar disorder	9.75e-06	6.41e-05	CbGpPWpGaD
Propiomazine—HTR2C—Signaling Pathways—DRD2—bipolar disorder	9.73e-06	6.39e-05	CbGpPWpGaD
Propiomazine—ADRA1B—GPCR downstream signaling—POMC—bipolar disorder	9.71e-06	6.38e-05	CbGpPWpGaD
Propiomazine—CHRM4—Signaling Pathways—NRG1—bipolar disorder	9.68e-06	6.36e-05	CbGpPWpGaD
Propiomazine—CHRM2—Signaling Pathways—TAC1—bipolar disorder	9.66e-06	6.34e-05	CbGpPWpGaD
Propiomazine—HTR2A—Signaling Pathways—HTR2C—bipolar disorder	9.65e-06	6.34e-05	CbGpPWpGaD
Propiomazine—HTR2A—Signaling Pathways—DRD1—bipolar disorder	9.65e-06	6.34e-05	CbGpPWpGaD
Propiomazine—ADRA1A—Signaling Pathways—TAC1—bipolar disorder	9.63e-06	6.33e-05	CbGpPWpGaD
Propiomazine—HRH1—Signaling Pathways—DRD1—bipolar disorder	9.63e-06	6.32e-05	CbGpPWpGaD
Propiomazine—HRH1—Signaling Pathways—HTR2C—bipolar disorder	9.63e-06	6.32e-05	CbGpPWpGaD
Propiomazine—CHRM1—Signaling Pathways—HTR2C—bipolar disorder	9.6e-06	6.3e-05	CbGpPWpGaD
Propiomazine—CHRM1—Signaling Pathways—DRD1—bipolar disorder	9.6e-06	6.3e-05	CbGpPWpGaD
Propiomazine—CHRM3—Signaling Pathways—HTR2C—bipolar disorder	9.57e-06	6.28e-05	CbGpPWpGaD
Propiomazine—CHRM3—Signaling Pathways—DRD1—bipolar disorder	9.57e-06	6.28e-05	CbGpPWpGaD
Propiomazine—DRD2—Signaling Pathways—NTRK2—bipolar disorder	9.54e-06	6.26e-05	CbGpPWpGaD
Propiomazine—DRD2—Signaling Pathways—DRD3—bipolar disorder	9.5e-06	6.24e-05	CbGpPWpGaD
Propiomazine—CHRM2—Signaling Pathways—DRD1—bipolar disorder	9.47e-06	6.22e-05	CbGpPWpGaD
Propiomazine—CHRM2—Signaling Pathways—HTR2C—bipolar disorder	9.47e-06	6.22e-05	CbGpPWpGaD
Propiomazine—DRD2—Signaling Pathways—GSK3A—bipolar disorder	9.45e-06	6.21e-05	CbGpPWpGaD
Propiomazine—ADRA1A—Signaling Pathways—HTR2C—bipolar disorder	9.45e-06	6.2e-05	CbGpPWpGaD
Propiomazine—ADRA1A—Signaling Pathways—DRD1—bipolar disorder	9.45e-06	6.2e-05	CbGpPWpGaD
Propiomazine—ADRA1B—Signaling Pathways—ADCY2—bipolar disorder	9.41e-06	6.18e-05	CbGpPWpGaD
Propiomazine—HTR2A—Signaling Pathways—NTRK2—bipolar disorder	9.39e-06	6.16e-05	CbGpPWpGaD
Propiomazine—ADRA1B—Signaling Pathways—TCF7L2—bipolar disorder	9.38e-06	6.16e-05	CbGpPWpGaD
Propiomazine—HRH1—Signaling Pathways—NTRK2—bipolar disorder	9.36e-06	6.15e-05	CbGpPWpGaD
Propiomazine—HTR2A—Signaling Pathways—DRD3—bipolar disorder	9.34e-06	6.14e-05	CbGpPWpGaD
Propiomazine—CHRM1—Signaling Pathways—NTRK2—bipolar disorder	9.33e-06	6.13e-05	CbGpPWpGaD
Propiomazine—HRH1—Signaling Pathways—DRD3—bipolar disorder	9.32e-06	6.12e-05	CbGpPWpGaD
Propiomazine—ADRA1B—Signaling Pathways—DRD2—bipolar disorder	9.32e-06	6.12e-05	CbGpPWpGaD
Propiomazine—CHRM3—Signaling Pathways—NTRK2—bipolar disorder	9.31e-06	6.11e-05	CbGpPWpGaD
Propiomazine—HTR2A—Signaling Pathways—GSK3A—bipolar disorder	9.3e-06	6.11e-05	CbGpPWpGaD
Propiomazine—CHRM1—Signaling Pathways—DRD3—bipolar disorder	9.29e-06	6.1e-05	CbGpPWpGaD
Propiomazine—HRH1—Signaling Pathways—GSK3A—bipolar disorder	9.28e-06	6.1e-05	CbGpPWpGaD
Propiomazine—CHRM5—Signaling Pathways—NRG1—bipolar disorder	9.27e-06	6.09e-05	CbGpPWpGaD
Propiomazine—CHRM3—Signaling Pathways—DRD3—bipolar disorder	9.26e-06	6.08e-05	CbGpPWpGaD
Propiomazine—CHRM1—Signaling Pathways—GSK3A—bipolar disorder	9.25e-06	6.08e-05	CbGpPWpGaD
Propiomazine—CHRM3—Signaling Pathways—GSK3A—bipolar disorder	9.22e-06	6.06e-05	CbGpPWpGaD
Propiomazine—DRD2—Signaling Pathways—DRD4—bipolar disorder	9.22e-06	6.05e-05	CbGpPWpGaD
Propiomazine—CHRM2—Signaling Pathways—NTRK2—bipolar disorder	9.21e-06	6.05e-05	CbGpPWpGaD
Propiomazine—HTR2C—Signaling by GPCR—POMC—bipolar disorder	9.21e-06	6.05e-05	CbGpPWpGaD
Propiomazine—ADRA1A—Signaling Pathways—NTRK2—bipolar disorder	9.19e-06	6.03e-05	CbGpPWpGaD
Propiomazine—CHRM2—Signaling Pathways—DRD3—bipolar disorder	9.17e-06	6.02e-05	CbGpPWpGaD
Propiomazine—ADRA1A—Signaling Pathways—DRD3—bipolar disorder	9.15e-06	6.01e-05	CbGpPWpGaD
Propiomazine—CHRM2—Signaling Pathways—GSK3A—bipolar disorder	9.13e-06	6e-05	CbGpPWpGaD
Propiomazine—ADRA1A—Signaling Pathways—GSK3A—bipolar disorder	9.11e-06	5.98e-05	CbGpPWpGaD
Propiomazine—HTR2A—Signaling Pathways—DRD4—bipolar disorder	9.07e-06	5.96e-05	CbGpPWpGaD
Propiomazine—HRH1—Signaling Pathways—DRD4—bipolar disorder	9.05e-06	5.94e-05	CbGpPWpGaD
Propiomazine—CHRM1—Signaling Pathways—DRD4—bipolar disorder	9.02e-06	5.92e-05	CbGpPWpGaD
Propiomazine—CHRM3—Signaling Pathways—DRD4—bipolar disorder	8.99e-06	5.91e-05	CbGpPWpGaD
Propiomazine—DRD2—GPCR downstream signaling—POMC—bipolar disorder	8.95e-06	5.88e-05	CbGpPWpGaD
Propiomazine—CHRM2—Signaling Pathways—DRD4—bipolar disorder	8.91e-06	5.85e-05	CbGpPWpGaD
Propiomazine—ADRA1A—Signaling Pathways—DRD4—bipolar disorder	8.88e-06	5.83e-05	CbGpPWpGaD
Propiomazine—DRD4—Signaling Pathways—HTR2A—bipolar disorder	8.85e-06	5.81e-05	CbGpPWpGaD
Propiomazine—DRD1—Signaling Pathways—NRG1—bipolar disorder	8.84e-06	5.8e-05	CbGpPWpGaD
Propiomazine—ADRA1B—Signaling by GPCR—POMC—bipolar disorder	8.82e-06	5.79e-05	CbGpPWpGaD
Propiomazine—HTR2A—GPCR downstream signaling—POMC—bipolar disorder	8.81e-06	5.79e-05	CbGpPWpGaD
Propiomazine—HTR2C—Signaling Pathways—NTRK1—bipolar disorder	8.81e-06	5.79e-05	CbGpPWpGaD
Propiomazine—HRH1—GPCR downstream signaling—POMC—bipolar disorder	8.79e-06	5.77e-05	CbGpPWpGaD
Propiomazine—CHRM1—GPCR downstream signaling—POMC—bipolar disorder	8.76e-06	5.76e-05	CbGpPWpGaD
Propiomazine—CHRM3—GPCR downstream signaling—POMC—bipolar disorder	8.74e-06	5.74e-05	CbGpPWpGaD
Propiomazine—CHRM4—Signaling Pathways—HTR2A—bipolar disorder	8.73e-06	5.73e-05	CbGpPWpGaD
Propiomazine—ADRA1D—Signaling Pathways—NRG1—bipolar disorder	8.72e-06	5.73e-05	CbGpPWpGaD
Propiomazine—DRD2—Signaling Pathways—ADCY2—bipolar disorder	8.68e-06	5.7e-05	CbGpPWpGaD
Propiomazine—CHRM3—Metabolism—COMT—bipolar disorder	8.67e-06	5.69e-05	CbGpPWpGaD
Propiomazine—CHRM2—GPCR downstream signaling—POMC—bipolar disorder	8.65e-06	5.68e-05	CbGpPWpGaD
Propiomazine—DRD2—Signaling Pathways—TCF7L2—bipolar disorder	8.65e-06	5.68e-05	CbGpPWpGaD
Propiomazine—ADRA1A—GPCR downstream signaling—POMC—bipolar disorder	8.63e-06	5.67e-05	CbGpPWpGaD
Propiomazine—CHRM3—Metabolism—MAOA—bipolar disorder	8.61e-06	5.65e-05	CbGpPWpGaD
Propiomazine—HTR2C—Signaling Pathways—S100B—bipolar disorder	8.56e-06	5.62e-05	CbGpPWpGaD
Propiomazine—HTR2A—Signaling Pathways—ADCY2—bipolar disorder	8.54e-06	5.61e-05	CbGpPWpGaD
Propiomazine—HRH1—Signaling Pathways—ADCY2—bipolar disorder	8.52e-06	5.6e-05	CbGpPWpGaD
Propiomazine—HTR2A—Signaling Pathways—TCF7L2—bipolar disorder	8.51e-06	5.59e-05	CbGpPWpGaD
Propiomazine—CHRM1—Signaling Pathways—ADCY2—bipolar disorder	8.49e-06	5.58e-05	CbGpPWpGaD
Propiomazine—HRH1—Signaling Pathways—TCF7L2—bipolar disorder	8.49e-06	5.58e-05	CbGpPWpGaD
Propiomazine—CHRM3—Signaling Pathways—ADCY2—bipolar disorder	8.47e-06	5.56e-05	CbGpPWpGaD
Propiomazine—CHRM1—Signaling Pathways—TCF7L2—bipolar disorder	8.46e-06	5.56e-05	CbGpPWpGaD
Propiomazine—HTR2A—Signaling Pathways—DRD2—bipolar disorder	8.45e-06	5.55e-05	CbGpPWpGaD
Propiomazine—CHRM3—Signaling Pathways—TCF7L2—bipolar disorder	8.44e-06	5.54e-05	CbGpPWpGaD
Propiomazine—ADRA1B—Signaling Pathways—NTRK1—bipolar disorder	8.43e-06	5.54e-05	CbGpPWpGaD
Propiomazine—HRH1—Signaling Pathways—DRD2—bipolar disorder	8.43e-06	5.54e-05	CbGpPWpGaD
Propiomazine—CHRM1—Signaling Pathways—DRD2—bipolar disorder	8.4e-06	5.52e-05	CbGpPWpGaD
Propiomazine—CHRM2—Signaling Pathways—ADCY2—bipolar disorder	8.38e-06	5.51e-05	CbGpPWpGaD
Propiomazine—CHRM3—Signaling Pathways—DRD2—bipolar disorder	8.38e-06	5.5e-05	CbGpPWpGaD
Propiomazine—CHRM5—Signaling Pathways—HTR2A—bipolar disorder	8.36e-06	5.49e-05	CbGpPWpGaD
Propiomazine—ADRA1A—Signaling Pathways—ADCY2—bipolar disorder	8.36e-06	5.49e-05	CbGpPWpGaD
Propiomazine—CHRM2—Signaling Pathways—TCF7L2—bipolar disorder	8.35e-06	5.49e-05	CbGpPWpGaD
Propiomazine—ADRA1A—Signaling Pathways—TCF7L2—bipolar disorder	8.33e-06	5.47e-05	CbGpPWpGaD
Propiomazine—CHRM2—Signaling Pathways—DRD2—bipolar disorder	8.3e-06	5.45e-05	CbGpPWpGaD
Propiomazine—ADRA1A—Signaling Pathways—DRD2—bipolar disorder	8.27e-06	5.43e-05	CbGpPWpGaD
Propiomazine—ADRA1B—Signaling Pathways—S100B—bipolar disorder	8.2e-06	5.38e-05	CbGpPWpGaD
Propiomazine—DRD2—Signaling by GPCR—POMC—bipolar disorder	8.13e-06	5.34e-05	CbGpPWpGaD
Propiomazine—HTR2A—Signaling by GPCR—POMC—bipolar disorder	8e-06	5.25e-05	CbGpPWpGaD
Propiomazine—HRH1—Signaling by GPCR—POMC—bipolar disorder	7.98e-06	5.24e-05	CbGpPWpGaD
Propiomazine—DRD1—Signaling Pathways—HTR2A—bipolar disorder	7.97e-06	5.23e-05	CbGpPWpGaD
Propiomazine—CHRM1—Signaling by GPCR—POMC—bipolar disorder	7.96e-06	5.23e-05	CbGpPWpGaD
Propiomazine—CHRM3—Signaling by GPCR—POMC—bipolar disorder	7.93e-06	5.21e-05	CbGpPWpGaD
Propiomazine—ADRA1D—Signaling Pathways—HTR2A—bipolar disorder	7.86e-06	5.16e-05	CbGpPWpGaD
Propiomazine—CHRM2—Signaling by GPCR—POMC—bipolar disorder	7.86e-06	5.16e-05	CbGpPWpGaD
Propiomazine—ADRA1A—Signaling by GPCR—POMC—bipolar disorder	7.83e-06	5.14e-05	CbGpPWpGaD
Propiomazine—DRD2—Signaling Pathways—NTRK1—bipolar disorder	7.78e-06	5.11e-05	CbGpPWpGaD
Propiomazine—HTR2A—Signaling Pathways—NTRK1—bipolar disorder	7.65e-06	5.02e-05	CbGpPWpGaD
Propiomazine—HRH1—Signaling Pathways—NTRK1—bipolar disorder	7.63e-06	5.01e-05	CbGpPWpGaD
Propiomazine—CHRM1—Signaling Pathways—NTRK1—bipolar disorder	7.61e-06	5e-05	CbGpPWpGaD
Propiomazine—CHRM3—Signaling Pathways—NTRK1—bipolar disorder	7.59e-06	4.98e-05	CbGpPWpGaD
Propiomazine—HTR2C—Signaling Pathways—NRG1—bipolar disorder	7.56e-06	4.96e-05	CbGpPWpGaD
Propiomazine—DRD2—Signaling Pathways—S100B—bipolar disorder	7.56e-06	4.96e-05	CbGpPWpGaD
Propiomazine—CHRM2—Signaling Pathways—NTRK1—bipolar disorder	7.51e-06	4.93e-05	CbGpPWpGaD
Propiomazine—ADRA1A—Signaling Pathways—NTRK1—bipolar disorder	7.49e-06	4.92e-05	CbGpPWpGaD
Propiomazine—HTR2A—Signaling Pathways—S100B—bipolar disorder	7.44e-06	4.88e-05	CbGpPWpGaD
Propiomazine—HRH1—Signaling Pathways—S100B—bipolar disorder	7.42e-06	4.87e-05	CbGpPWpGaD
Propiomazine—CHRM1—Signaling Pathways—S100B—bipolar disorder	7.4e-06	4.86e-05	CbGpPWpGaD
Propiomazine—CHRM3—Signaling Pathways—S100B—bipolar disorder	7.37e-06	4.84e-05	CbGpPWpGaD
Propiomazine—CHRM2—Signaling Pathways—S100B—bipolar disorder	7.3e-06	4.8e-05	CbGpPWpGaD
Propiomazine—ADRA1A—Signaling Pathways—S100B—bipolar disorder	7.28e-06	4.78e-05	CbGpPWpGaD
Propiomazine—ADRA1B—Signaling Pathways—NRG1—bipolar disorder	7.24e-06	4.75e-05	CbGpPWpGaD
Propiomazine—DRD4—Signaling Pathways—GSK3B—bipolar disorder	7.12e-06	4.68e-05	CbGpPWpGaD
Propiomazine—DRD4—Signaling Pathways—POMC—bipolar disorder	7.07e-06	4.64e-05	CbGpPWpGaD
Propiomazine—CHRM4—Signaling Pathways—GSK3B—bipolar disorder	7.03e-06	4.62e-05	CbGpPWpGaD
Propiomazine—DRD4—Signaling Pathways—INS—bipolar disorder	7.03e-06	4.62e-05	CbGpPWpGaD
Propiomazine—CHRM3—Metabolism—MTHFR—bipolar disorder	7.01e-06	4.6e-05	CbGpPWpGaD
Propiomazine—CHRM4—Signaling Pathways—POMC—bipolar disorder	6.97e-06	4.58e-05	CbGpPWpGaD
Propiomazine—CHRM4—Signaling Pathways—INS—bipolar disorder	6.93e-06	4.55e-05	CbGpPWpGaD
Propiomazine—HTR2C—Signaling Pathways—HTR2A—bipolar disorder	6.82e-06	4.48e-05	CbGpPWpGaD
Propiomazine—CHRM5—Signaling Pathways—GSK3B—bipolar disorder	6.73e-06	4.42e-05	CbGpPWpGaD
Propiomazine—CHRM5—Signaling Pathways—POMC—bipolar disorder	6.68e-06	4.38e-05	CbGpPWpGaD
Propiomazine—DRD2—Signaling Pathways—NRG1—bipolar disorder	6.67e-06	4.38e-05	CbGpPWpGaD
Propiomazine—CHRM5—Signaling Pathways—INS—bipolar disorder	6.64e-06	4.36e-05	CbGpPWpGaD
Propiomazine—HTR2A—Signaling Pathways—NRG1—bipolar disorder	6.56e-06	4.31e-05	CbGpPWpGaD
Propiomazine—HRH1—Signaling Pathways—NRG1—bipolar disorder	6.55e-06	4.3e-05	CbGpPWpGaD
Propiomazine—CHRM1—Signaling Pathways—NRG1—bipolar disorder	6.53e-06	4.29e-05	CbGpPWpGaD
Propiomazine—ADRA1B—Signaling Pathways—HTR2A—bipolar disorder	6.52e-06	4.28e-05	CbGpPWpGaD
Propiomazine—CHRM3—Signaling Pathways—NRG1—bipolar disorder	6.51e-06	4.27e-05	CbGpPWpGaD
Propiomazine—CHRM2—Signaling Pathways—NRG1—bipolar disorder	6.44e-06	4.23e-05	CbGpPWpGaD
Propiomazine—ADRA1A—Signaling Pathways—NRG1—bipolar disorder	6.43e-06	4.22e-05	CbGpPWpGaD
Propiomazine—DRD1—Signaling Pathways—GSK3B—bipolar disorder	6.41e-06	4.21e-05	CbGpPWpGaD
Propiomazine—DRD1—Signaling Pathways—POMC—bipolar disorder	6.36e-06	4.18e-05	CbGpPWpGaD
Propiomazine—ADRA1D—Signaling Pathways—GSK3B—bipolar disorder	6.33e-06	4.16e-05	CbGpPWpGaD
Propiomazine—DRD1—Signaling Pathways—INS—bipolar disorder	6.33e-06	4.16e-05	CbGpPWpGaD
Propiomazine—ADRA1D—Signaling Pathways—POMC—bipolar disorder	6.28e-06	4.12e-05	CbGpPWpGaD
Propiomazine—ADRA1D—Signaling Pathways—INS—bipolar disorder	6.24e-06	4.1e-05	CbGpPWpGaD
Propiomazine—DRD2—Signaling Pathways—HTR2A—bipolar disorder	6.01e-06	3.95e-05	CbGpPWpGaD
Propiomazine—HRH1—Signaling Pathways—HTR2A—bipolar disorder	5.91e-06	3.88e-05	CbGpPWpGaD
Propiomazine—CHRM1—Signaling Pathways—HTR2A—bipolar disorder	5.89e-06	3.87e-05	CbGpPWpGaD
Propiomazine—CHRM3—Signaling Pathways—HTR2A—bipolar disorder	5.87e-06	3.85e-05	CbGpPWpGaD
Propiomazine—CHRM2—Signaling Pathways—HTR2A—bipolar disorder	5.81e-06	3.82e-05	CbGpPWpGaD
Propiomazine—ADRA1A—Signaling Pathways—HTR2A—bipolar disorder	5.8e-06	3.81e-05	CbGpPWpGaD
Propiomazine—CHRM3—Metabolism—POMC—bipolar disorder	5.6e-06	3.68e-05	CbGpPWpGaD
Propiomazine—CHRM3—Metabolism—INS—bipolar disorder	5.57e-06	3.66e-05	CbGpPWpGaD
Propiomazine—HTR2C—Signaling Pathways—GSK3B—bipolar disorder	5.49e-06	3.6e-05	CbGpPWpGaD
Propiomazine—HTR2C—Signaling Pathways—POMC—bipolar disorder	5.44e-06	3.57e-05	CbGpPWpGaD
Propiomazine—HTR2C—Signaling Pathways—INS—bipolar disorder	5.41e-06	3.55e-05	CbGpPWpGaD
Propiomazine—ADRA1B—Signaling Pathways—GSK3B—bipolar disorder	5.25e-06	3.45e-05	CbGpPWpGaD
Propiomazine—ADRA1B—Signaling Pathways—POMC—bipolar disorder	5.21e-06	3.42e-05	CbGpPWpGaD
Propiomazine—ADRA1B—Signaling Pathways—INS—bipolar disorder	5.18e-06	3.4e-05	CbGpPWpGaD
Propiomazine—DRD2—Signaling Pathways—GSK3B—bipolar disorder	4.84e-06	3.18e-05	CbGpPWpGaD
Propiomazine—DRD2—Signaling Pathways—POMC—bipolar disorder	4.8e-06	3.15e-05	CbGpPWpGaD
Propiomazine—DRD2—Signaling Pathways—INS—bipolar disorder	4.78e-06	3.14e-05	CbGpPWpGaD
Propiomazine—HTR2A—Signaling Pathways—GSK3B—bipolar disorder	4.76e-06	3.13e-05	CbGpPWpGaD
Propiomazine—HRH1—Signaling Pathways—GSK3B—bipolar disorder	4.75e-06	3.12e-05	CbGpPWpGaD
Propiomazine—CHRM1—Signaling Pathways—GSK3B—bipolar disorder	4.74e-06	3.11e-05	CbGpPWpGaD
Propiomazine—HTR2A—Signaling Pathways—POMC—bipolar disorder	4.73e-06	3.1e-05	CbGpPWpGaD
Propiomazine—CHRM3—Signaling Pathways—GSK3B—bipolar disorder	4.72e-06	3.1e-05	CbGpPWpGaD
Propiomazine—HRH1—Signaling Pathways—POMC—bipolar disorder	4.72e-06	3.1e-05	CbGpPWpGaD
Propiomazine—CHRM1—Signaling Pathways—POMC—bipolar disorder	4.7e-06	3.09e-05	CbGpPWpGaD
Propiomazine—HTR2A—Signaling Pathways—INS—bipolar disorder	4.7e-06	3.09e-05	CbGpPWpGaD
Propiomazine—HRH1—Signaling Pathways—INS—bipolar disorder	4.69e-06	3.08e-05	CbGpPWpGaD
Propiomazine—CHRM3—Signaling Pathways—POMC—bipolar disorder	4.69e-06	3.08e-05	CbGpPWpGaD
Propiomazine—CHRM2—Signaling Pathways—GSK3B—bipolar disorder	4.68e-06	3.07e-05	CbGpPWpGaD
Propiomazine—CHRM1—Signaling Pathways—INS—bipolar disorder	4.68e-06	3.07e-05	CbGpPWpGaD
Propiomazine—ADRA1A—Signaling Pathways—GSK3B—bipolar disorder	4.67e-06	3.06e-05	CbGpPWpGaD
Propiomazine—CHRM3—Signaling Pathways—INS—bipolar disorder	4.66e-06	3.06e-05	CbGpPWpGaD
Propiomazine—CHRM2—Signaling Pathways—POMC—bipolar disorder	4.64e-06	3.05e-05	CbGpPWpGaD
Propiomazine—ADRA1A—Signaling Pathways—POMC—bipolar disorder	4.63e-06	3.04e-05	CbGpPWpGaD
Propiomazine—CHRM2—Signaling Pathways—INS—bipolar disorder	4.62e-06	3.03e-05	CbGpPWpGaD
Propiomazine—ADRA1A—Signaling Pathways—INS—bipolar disorder	4.6e-06	3.02e-05	CbGpPWpGaD
